HCPLive
NOVEMBER 25, 2024
Emapalumab may improve outcomes in patients with MAS whose disease didn’t respond to steroid therapy and mitigate the need for more toxic therapies.
Becker's Hospital Review - Cardiology
NOVEMBER 25, 2024
Healthgrades published its 2025 Specialty Excellence Awards recipients Oct. 22. Of those, 97 hospitals were recognized for delivering superior clinical outcomes in cardiac care for heart bypass surgery, coronary interventional procedures, heart attack treatment, heart failure treatment and heart valve surgery.
HCPLive
NOVEMBER 25, 2024
Panelists discuss how IgA nephropathy affects patients’ quality of life, addressing both the physical symptoms and the emotional challenges associated with the condition.
Science Daily - Heart Disease
NOVEMBER 25, 2024
The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes shows they have significant benefits in people with and without diabetes.
HCPLive
NOVEMBER 25, 2024
Hypovitaminosis D was more prevalent in patients with lupus nephritis compared to patients with systemic lupus erythematosus without kidney disease.
Dr. Smith's ECG Blog
NOVEMBER 25, 2024
Introductory Angiography Guide To find the guide later, go to the banner at the top of the blog: This blog is dedicated to improving understanding of ECGs in the context of emergency medicine. A substantial proportion of cases discussed include diagnostic angiography. Attaining expertise in angiography requires dedication and practice. What follows is an introduction to angiography -- a guide meant for people with no prior experience interpreting angiograms.
HCPLive
NOVEMBER 25, 2024
Panelists discuss how early detection of chronic kidney disease (CKD) in stages 2 and 3 can improve patient outcomes across various specialties, including nephrology, cardiology, and primary care.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
HCPLive
NOVEMBER 25, 2024
The Urate-Lowering Therapy to Acute Treatment Ratio (ULTrA) was linked to fewer gout-related hospital admissions.
HeartRhythm
NOVEMBER 25, 2024
Cardiac implantable electronic device (CIED) infection still lacks standardized and universally accepted diagnostic criteria. Current EHRA criteria1 largely adapt to CIED Infections the Modified Duke criteria2 and ESC 2015 criteria,3 which were developed for native valve endocarditis and later adapted to prosthetic valve endocarditis.
American College of Cardiology
NOVEMBER 25, 2024
Is a pharmacist-led home sotalol loading protocol using an ambulatory electrocardiographic (ECG) device for adverse event monitoring feasible, safe, and efficacious?
Medical Xpress - Cardiology
NOVEMBER 25, 2024
Research conducted across 12 hospitals in China has discovered that combining linear ablation with ethanol infusion via the vein of Marshall (EIVOM) alongside pulmonary vein isolation (PVI) significantly improves sinus rhythm maintenance in patients suffering from persistent atrial fibrillation.
HCPLive
NOVEMBER 25, 2024
Panelists discuss the importance of screening and monitoring family members of individuals with IgA nephropathy, noting that up to 15% of cases are familial and outlining recommendations for the frequency of such assessments.
Journal of Cardiothoracic Surgery
NOVEMBER 25, 2024
Tricuspid valve replacement (TVR) is required when repair is not feasible, and it continues to be a relatively high-risk procedure owing to the complex medical and/or surgical profile of patients. The choice b.
HCPLive
NOVEMBER 25, 2024
These data, presented at ACR 2024, demonstrate that response was maintained at 2 years among those with psoriatic arthritis who responded to bimekizumab at Week 16.
Cardiovascular Diabetology
NOVEMBER 25, 2024
Diabetic cardiomyopathy (DCM) is a severe cardiovascular complication of diabetes characterized by myocardial hypertrophy, fibrosis, and impaired cardiac function. Fibroblast growth factor 21 (FGF21) has emerg.
HCPLive
NOVEMBER 25, 2024
Lowering serum urate level to less than 6 mg/dL was not linked to an elevated risk of severe or end-stage kidney disease progression in patients with gout.
Open Heart
NOVEMBER 25, 2024
Background Valvular heart disease (VHD) represents a significant burden on healthcare systems worldwide, necessitating specialised care through multidisciplinary valve clinics. However, there is a lack of a standardised training and certification framework for clinical scientists and specialist physiologists (CSSPs) working within specialist valve clinics (SVCs).
HCPLive
NOVEMBER 25, 2024
At ACR, HCPLive spoke with Erin Treemarcki on a survey that showed many rheumatologists do not use established enthesitis scoring measures for children.
Dr. Paddy Barrett
NOVEMBER 25, 2024
The Heart Health Formula is available from today until Sunday, Dec 1st. You might have received an email saying today is the LAST day of availability, but it's not. It is the first day. Apologies for the earlier email. This was a scheduling error on our part. But if you want to pick up the Heart Health Formula for 30% off, you can do so from today until Sunday.
HCPLive
NOVEMBER 25, 2024
This post-hoc analysis demonstrated an association between work productivity and stringent disease control criteria for those with psoriatic arthritis.
Frontiers in Cardiovascular Medicine
NOVEMBER 25, 2024
Heat exposure could cause organ injuries leading to multi-organ failure. This case report describes a cardiopulmonary healthy 61-year-old woman who was admitted to our university hospital in an unconscious state after spending more than 30 min in an 80°C sauna. Initial radiological imaging revealed no pathological findings. Laboratory results revealed a rapidly progressing disseminated intravascular coagulation (“DIC”) and a clinically asymptomatic COVID-19 infection.
HCPLive
NOVEMBER 25, 2024
At ACR, HCPLive spoke with Ashima Makol, MD, about factors linked to a worse health-related quality of life in patients with early systemic sclerosis.
Frontiers in Cardiovascular Medicine
NOVEMBER 25, 2024
IntroductionCardiovascular diseases include myocardial infarction, a high mortality disease. Myocardial infarction patients are becoming younger, typically defined as patients under 45 years of age. This study analyzes the relevant papers on myocardial infarction in youth in the Web of Science Core Collection (WoSCC) between 1980 and 2023.MethodsIt uses bibliometric methods to systematically understand the current status and development trend of research in this field.
DAIC
NOVEMBER 25, 2024
tim.hodson Mon, 11/25/2024 - 18:06 Nov. 22, 2024 — BridgeBio Pharma, Inc. recently announced that the U.S. Food and Drug Administration (FDA) approved Attruby (acoramidis), an orally-administered near-complete (≥90%) stabilizer of Transthyretin (TTR) for the treatment of adults with ATTR-CM to reduce cardiovascular death and cardiovascular-related hospitalization.
Frontiers in Cardiovascular Medicine
NOVEMBER 25, 2024
BackgroundAtherosclerosis, a complex chronic vascular disorder with multifactorial etiology, stands as the primary culprit behind consequential cardiovascular events, imposing a substantial societal and economic burden. Nevertheless, our current understanding of its pathogenesis remains imprecise. In this investigation, our objective is to establish computational models elucidating molecular-level markers associated with atherosclerosis.
Becker's Hospital Review - Cardiology
NOVEMBER 25, 2024
Ninety-five percent of CPR training manikins on the global market are flat-chested, possibly contributing to disproportionate survival outcomes for women after cardiac arrest, according to a study published Nov. 21 in Health Promotional International.
Frontiers in Cardiovascular Medicine
NOVEMBER 25, 2024
Cardiovascular diseases (CVDs) encompass a range of disorders affecting the heart and blood vessels, such as coronary heart disease, cerebrovascular disease (e.g., stroke), peripheral arterial disease, congenital heart anomalies, deep vein thrombosis, and pulmonary embolism. CVDs are often referred to as the leading cause of mortality worldwide. Recent advancements in deep sequencing have unveiled a plethora of noncoding RNA transcripts, including circular RNAs (circRNAs), which play pivotal rol
Med Page Today
NOVEMBER 25, 2024
(MedPage Today) -- Acoramidis (Attruby) gained FDA approval for treating wild-type or variant transthyretin (TTR) amyloidosis cardiomyopathy (ATTR-CM), BridgeBio Pharma announced. Offering patients near-complete TTR stabilization in an oral tablet.
Frontiers in Cardiovascular Medicine
NOVEMBER 25, 2024
Pathological transdifferentiation, where differentiated cells aberrantly transform into other cell types that exacerbate disease rather than promote healing, represents a novel and significant concept. This perspective discusses its role and potential targeting in cardiovascular diseases and chronic inflammation. Current therapies mainly focus on mitigating early inflammatory response through proinflammatory cytokines and pathways targeting, including corticosteroids, TNF-α inhibitors, IL-1β mon
Becker's Hospital Review - Cardiology
NOVEMBER 25, 2024
Memorial Hospital at Gulfport (Miss.) reported the highest Medicare payment of $38,459 for heart attack care between July 1, 2020, and June 30, 2023, according to CMS data published Oct. 30.
Frontiers in Cardiovascular Medicine
NOVEMBER 25, 2024
BackgroundIt remains unclear whether the current recommended ablation index (AI) value is suitable for individualized catheter ablation. Prior research has established that the elimination of the negative component of the unipolar electrogram (UP-EGM) applications reflects the formation of transmural lesion during radiofrequency ablation. The aim of this study was to explore the relationship between AI values when UP-EGM turns positive during pulmonary vein isolation and recommended AI values.Me
Cardiometabolic Health Congress
NOVEMBER 25, 2024
If you’re looking to revisit or explore the sessions from the 19th Annual Cardiometabolic Health Congress (CMHC), we’ve got good news—on-demand access is now available! Below, we answer the most common questions about CMHC On-Demand to help you make the most of this resource and stay updated on key developments in cardiometabolic health. If you attended the 19th Annual Cardiometabolic Health Congress (CMHC), please reach out to info@cardiometabolichealth.org and we will provide you with a compli
Heart BMJ
NOVEMBER 25, 2024
Cardiac rehabilitation (CR) is a multidisciplinary supervised programme which typically consists of tailored exercise and education on lifestyle management and risk factor modification in cardiac patients. Participation in CR reduces morbidity and mortality, while improving quality of life following major cardiovascular events. Despite the benefits of CR, it is underutilised, generally in the 20%–30% range for eligible patients.
Frontiers in Cardiovascular Medicine
NOVEMBER 25, 2024
BackgroundThe relationship between serial changes in physical activity and the risk of developing atrial fibrillation (AF) has been rarely studied.ObjectivesTo evaluate the association between changes in physical activity over time and the incidence of AF.MethodsA total of 11,828 participants without AF at baseline (visit 1: 1987–1989) from the ARIC Study were included.
Heart BMJ
NOVEMBER 25, 2024
Background Participation in regular exercise activities is recommended for patients with chronic heart failure. However, less is known about the effect of exercise in patients with genetic dilated cardiomyopathy (DCM). We sought to examine the effect of vigorousintensity training on physical capacity in patients with DCM caused by truncating titin variants (TTNtv).
HCPLive
NOVEMBER 25, 2024
Panelists discuss the high rates of missed chronic kidney disease (CKD) diagnoses despite testing and the consequences of diagnosing CKD in patients with type 2 diabetes without administering treatment, including insights on how frequently this occurs among cardiologists and primary care providers.
Heart BMJ
NOVEMBER 25, 2024
Background Rapid Access Chest Pain Clinics (RACPC) are widely used for the outpatient assessment of chest pain, but there appears to be limited high-quality evidence justifying this model of care. This study aimed to review the literature to determine the effectiveness of RACPCs. Methods A systematic review of studies evaluating the effectiveness of RACPCs was conducted to assess the quality of the evidence supporting this model.
Expert insights. Personalized for you.
118 
Let's personalize your content